News Release 

Nobel Prize reflects perseverance in scientific research

Mary Ann Liebert, Inc./Genetic Engineering News

Research News

IMAGE

IMAGE: Topics cover both human and animal viral immunology, exploring viral-based immunological diseases, pathogenic mechanisms, and virus-associated tumor and cancer immunology. The Journal includes original research papers, review articles, and commentaries... view more 

Credit: Mary Ann Liebert, Inc., publishers

New Rochelle, NY, December 21, 2020--The 2020 Nobel Prize in Physiology or Medicine went to three researchers for their discovery of hepatitis C virus (HCV). The undying perseverance that it took to find and cure this elusive virus is eloquently detailed in the peer-reviewed journal Viral Immunology. Click here to read the article now.

Rodney S. Russell, PhD, Editor-in-Chief of Viral Immunology, from Memorial University of Newfoundland, St. John's, recounts his own research experience with HCV and tells the story of how the virus was discovered.

"The strongest theme I see in the field of HCV research is perseverance," says Dr. Russell. "Finding HCV was not easy, working with HCV was not easy, curing HCV was not easy, and even now, making an effective vaccine against HCV is proving not to be easy. What impresses me most about the thousands of scientists around the world who contributed to the study of this virus, even before it was discovered, was, and still is, their absolute unwillingness to quit."

###

About the Journal

Viral Immunology is an authoritative peer-reviewed journal published ten times a year in print and online. Topics cover both human and animal viral immunology, exploring viral-based immunological diseases, pathogenic mechanisms, and virus-associated tumor and cancer immunology. The Journal includes original research papers, review articles, and commentaries covering the spectrum of laboratory and clinical research and exploring developments in vaccines and diagnostics targeting viral infections. Tables of content and a sample issue may be viewed on the Viral Immunology website.

About the Publisher

Mary Ann Liebert, Inc., publishers) is known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research. Its biotechnology trade magazine, GEN (Genetic Engineering & Biotechnology News), was the first in its field and is today the industry's most widely read publication worldwide. A complete list of the firm's 90 journals, books, and newsmagazines is available on the Mary Ann Liebert, Inc., publishers website.

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.